Newcells Biotech
Signal active
Organization
Contact Information
Overview
Newcells Biotech are experts in the production of induced pluripotent stem cells (iPSCs) and their differentiation into a wide range of reliable and reproducible cell and tissue types. Their focus is to provide customers engaged in drug discovery, pre-clinical development and disease mechanism investigation, with the best quality cells and services.
About
Industries
Biotechnology, Health Care, Pharmaceutical, Medical, Medical Device, Therapeutics
Founded
2015
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Newcells Biotech headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Medical, Medical Device, Therapeutics sector. The company focuses on Biotechnology and has secured $1.2B in funding across 96 round(s). With a team of 1-10 employees, Newcells Biotech is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Newcells Biotech, raised $239.2K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$12.9M
Details
3
Newcells Biotech has raised a total of $12.9M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Seed | 2.6M | ||
| 2021 | Seed | 7.1M | ||
| 2015 | Seed | 239.2K |
Investors
Newcells Biotech is funded by 19 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| North East Innovation Fund | - | FUNDING ROUND - North East Innovation Fund | 3.0M |
| Alex Buchan | - | FUNDING ROUND - Alex Buchan | 239.2K |
| Newcells Biotech | - | FUNDING ROUND - Newcells Biotech | 239.2K |
| Northstar Ventures | - | FUNDING ROUND - Northstar Ventures | 239.2K |
Recent Activity
There is no recent news or activity for this profile.